Merck & Co Inc logo

Merck & Co Inc

MXN 1834.00 (+0.2%) Aug 18
P/E:
14.00
P/B:
5.35
Market Cap:
MXN 4.63T ($ 229.50B)
Enterprise V:
MXN 5.06T ($ 250.85B)
Volume:
123.00
Avg Vol (2M):
3.05K
Also Trade In:
Volume:
123.00
Market Cap MXN:
4.63T
Market Cap $:
229.50B
PE Ratio:
14.00
Avg Vol (2-Month):
3.05K
Enterprise Value MXN:
5.06T
Enterprise Value $:
250.85B
PB Ratio:
5.35
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Merck & Co Inc
NAICS : 325412 SIC : 2834
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Financials (Next Earnings Date:2022-10-27)

MEX:MRK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil MXN) 1,165,310.74
EPS (TTM) (MXN) 132.994
Beta -0.4
Volatility % 25.39
14-Day RSI 52.18
14-Day ATR (MXN) 24.435591
20-Day SMA (MXN) 1814.0825
12-1 Month Momentum % 22.73
52-Week Range (MXN) 1430 - 1956.25
Shares Outstanding (Mil) 2,533.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Document Form Filing Date
No Filing Data